An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Expert opinion on drug safety - 13(2014), 11 vom: Nov., Seite 1437-1442 |
| Beteiligte Personen: |
D'Amico, Mauro [VerfasserIn] |
|---|
| BKL: |
|---|
| Umfang: |
6 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1952740843 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1952740843 | ||
| 003 | DE-627 | ||
| 005 | 20230517092538.0 | ||
| 007 | tu | ||
| 008 | 141103s2014 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw141024_1 |
| 035 | |a (DE-627)OLC1952740843 | ||
| 035 | |a (DE-599)GBVOLC1952740843 | ||
| 035 | |a (KEY)0509195020141100013001101437observationalstudyofnasalcavitytoxicityincancerpat | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a D'Amico, Mauro |e verfasserin |4 aut | |
| 245 | 1 | 3 | |a An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab |
| 264 | 1 | |c 2014 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Pagano, Mauro |4 oth | |
| 700 | 1 | |a Pasa, Ambra |4 oth | |
| 700 | 1 | |a Puntoni, Matteo |4 oth | |
| 700 | 1 | |a Clavarezza, Matteo |4 oth | |
| 700 | 1 | |a Gennari, Alessandra |4 oth | |
| 700 | 1 | |a Gozza, Alberto |4 oth | |
| 700 | 1 | |a Zanardi, Silvia |4 oth | |
| 700 | 1 | |a Defferrari, Carlotta |4 oth | |
| 700 | 1 | |a Provinciali, Nicoletta |4 oth | |
| 700 | 1 | |a Campazzi, Eleonora |4 oth | |
| 700 | 1 | |a Campora, Sara |4 oth | |
| 700 | 1 | |a Paleari, Laura |4 oth | |
| 700 | 1 | |a Marra, Domenico |4 oth | |
| 700 | 1 | |a Petrera, Marilena |4 oth | |
| 700 | 1 | |a DeCensi, Andrea |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Expert opinion on drug safety |d London : Informa Healthcare, 2002 |g 13(2014), 11 vom: Nov., Seite 1437-1442 |w (DE-627)354542478 |w (DE-600)2088728-0 |w (DE-576)435515020 |x 1474-0338 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2014 |g number:11 |g month:11 |g pages:1437-1442 |g extent:6 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 13 |j 2014 |e 11 |c 11 |h 1437-1442 |g 6 | ||